An Empirical Study on the Impact of drug licensing on sales
Qi-hang Wang, Chen Cao, Yuan-jia HU
Available Online November 2018.
- https://doi.org/10.2991/icemaess-18.2018.65How to use a DOI?
- drug licensing, sales, T-test, Q-test
- To study the impact of drug licensing on its sales, and to provide a reference for drug development and corporation between pharma. METHODS: Based on the variables “license station”, “co-development or co-marketing”, “licensor in accord with key marketing company or not” and “time for drug licensing” which reflected drug licensing and sales, with SPSS statistical software, T-test and Q-test of drug licensing and the sales of drugs were carried out on the 151 sample drugs collected in IMS Health. RESULTS & CONCLUSIONS: Drugs with licensing activities have higher sales than those without licensing. There is no significant difference between co-development and co-marketing for the drugs, Licensor hold the key marketing right helps improve sales of drugs. The optimum time for drug licensing is phase Ⅲ.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Qi-hang Wang AU - Chen Cao AU - Yuan-jia HU PY - 2018/11 DA - 2018/11 TI - An Empirical Study on the Impact of drug licensing on sales BT - Proceedings of the 2018 5th International Conference on Education, Management, Arts, Economics and Social Science (ICEMAESS 2018) PB - Atlantis Press SP - 312 EP - 317 SN - 2352-5398 UR - https://doi.org/10.2991/icemaess-18.2018.65 DO - https://doi.org/10.2991/icemaess-18.2018.65 ID - Wang2018/11 ER -